Ashraf Awaad

Dr. Ashraf Awaad


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
SSSylvia Tharwat Shawky
Sylvia Tharwat Shawky
SMShaimaa Osama Makled
Shaimaa Osama Makled
AAAshraf Awaad
Ashraf Awaad
NBNabila Boraie
Nabila Boraie
The study aim was to develop an intravesical delivery system of quercetin for bladder cancer management in order to improve drug efficacy, attain a controlled release profile and extend the residence time inside the bladder. Either uncoated or chitosan coated quercetin-loaded solid lipid nanoparticles (SLNs) were prepared and evaluated in terms of colloidal, morphological and thermal characteristics. Drug encapsulation efficiency and its release behaviour were assessed. Furthermore, cytotoxicity of SLNs on T-24 cells was evaluated. Ex vivo studies were carried out using bovine bladder mucosa. Spherical SLNs (≈250 nm) ensured good entrapment efficiencies (EE > 97%) and sustained drug release up to 142 h. Cytotoxicity profile revealed concentration-dependent toxicity recording an IC50 in the range of 1.6–8.9 μg/mL quercetin. SLNs were further dispersed in in situ hydrogels comprising poloxamer 407 (20%) with mucoadhesive polymers. In situ gels exhibited acceptable gelation temperatures (around 25 °C) and long erosion time (24–27 h). SLNs loaded gels displayed remarkably enhanced retention on bladder tissues relative to SLNs dispersions. Coated SLNs exhibited better penetration abilities compared to uncoated ones, while coated SLNs dispersed in gel (G10C-St-QCT-SLNs-2) showed the highest penetration up to 350 μm. Hence, G10C-St-QCT-SLNs-2 could be considered as a platform for intravesical quercetin delivery.

17 February 2022 in Journal of Biochemical and Molecular Toxicology
Verified
Journal Article
Closed access
PDF file
WEWafaa M. Elsehly
Wafaa M. Elsehly
GMGhada M. Mourad
Ghada M. Mourad
RARADWA Ali ALY
RADWA Ali ALY
MKMarwa A. Kholief
Marwa A. Kholief
NENefertiti A. El-Nikhely
Nefertiti A. El-Nikhely
MennattAllah Hassan AttiaMennattAllah Hassan Attia
MennattAllah Hassan Attia

24 November 2022 in BMC Complementary Medicine and Therapies
Verified
Journal Article
Open access
PDF file
MEMarwa Essawy
Marwa Essawy
MMMostafa M. Mohamed
Mostafa M. Mohamed
HRHanaa S. Raslan
Hanaa S. Raslan
SRSalma T. Rafik
Salma T. Rafik
AAAshraf Awaad
Ashraf Awaad
OROmneya R. Ramadan
Omneya R. Ramadan
Background: Oral cancer, one of the most common cancers, has unimproved 5-years survival rate in the last 30 years and the chemo/radiotherapy-associated morbidity. Therefore, intervention strategies that evade harmful side effects of the conventional treatment modalities are of need. Herbal therapy as a complementary preventive/therapeutic modality has gained attention. Curcumin is one of the herbal compounds possessing unique anticancer activity and luminescent optical properties. However, its low water solubility limits its efficacy. In contrast, curcumin at the nanoscale shows altered physical properties with enhancing bioavailability. Methods: The current study evaluated the impact of nanocurcumin as an anti-oral cancer herbal remedy, comparing its efficacy against the native curcumin complement and conventional chemotherapeutic. An optimized polymeric-stabilized nanocurcumin was synthesized using the solvent-antisolvent precipitation technique. After assuring the solubility and biocompatibility of nanocurcumin, we determined its cytotoxic dose in treating the squamous cell carcinoma cell line. We then evaluated the anti-tumorigenic activity of the nano-herb in inhibiting wound closure and the cytological alterations of the treated cancer cells. Furthermore, the cellular uptake of the nanocurcumin was assessed depending on its autofluorescence. Results: The hydrophilic optimized nanocurcumin has a potent cancerous cytotoxicity at a lower dose (60.8 µg/mL) than the native curcumin particles (212.4 µg/mL) that precipitated on high doses hindering their cellular uptake. Moreover, the nanocurcumin showed differential targeting of the cancer cells over the normal fibroblasts with a selectivity index of 4.5. With the confocal microscopy, the luminescent nanoparticles showed gradual nuclear and cytoplasmic uptake with apparent apoptotic cell death, over the fluorescent doxorubicin with its necrotic effect. Furthermore, the nanocurcumin superiorly inhibited the migration of cancer cells by -25%. Conclusions: The bioavailable nanocurcumin has better apoptotic cytotoxicity. Moreover, its superior luminescence promotes the theranostic potentialities of the nano-herb combating oral cancer.

5 August 2022 in Oral Diseases
Verified
Journal Article
Closed access
MEMarwa Essawy
Marwa Essawy
SRSalma T. Rafik
Salma T. Rafik
AAAshraf Awaad
Ashraf Awaad
GMGhada M. Mourad
Ghada M. Mourad
SASamar El Achy
Samar El Achy

28 July 2020 in Egyptian Liver Journal
Verified
Journal Article
Open access
PDF file
AAAshraf Awaad
Ashraf Awaad
MKMaher A. Kamel
Maher A. Kamel
MMMagdy M. Mohamed
Magdy M. Mohamed
MHMadiha H. Helmy
Madiha H. Helmy
MYMagda I. Youssef
Magda I. Youssef
MHMarwa G. A. Hegazy
Marwa G. A. Hegazy
Background: Several molecular mechanisms contribute to the initiation and progression of nonalcoholic fatty liver disease (NAFLD); however, the exact mechanism is not completely understood. Cyclic adenosine monophosphate (cAMP) is one of the most promising pathways that regulates various cellular functions including lipid and carbohydrate metabolism. cAMP induces gene transcription through phosphorylation of the transcription factor, cAMP response element-binding protein (CREB). The action of cAMP is tightly regulated by its level and repression. Among the repressors, Inducible cAMP Early Repressor (ICER) is the only inducible CRE-binding protein. The present study aimed to evaluate the role of hepatic CREB level in the development of experimental NAFLD model to clarify the pathogenesis of the disease. NAFLD 35 male Wistar rats fed a high fat diet for a period of 14 weeks were studied compared with 35 control rats fed a standard diet. Five fasting rats were sacrificed each 2 weeks intervals for a period of 14 weeks. Results: NAFLD group revealed a remarkable duration—dependent elevation in cAMP and CREB levels in the liver tissue compared to control group (P value < 0.004, P value < 0.006, respectively). In contrast, ICER gene expression, as a dominant-negative regulator of CREB, was downregulated in the liver of NAFLD group compared to control group. We also demonstrated that CREB levels were positively correlated with liver function tests, and glucose homeostasis parameters. Conclusions: Our results indicate that cAMP/CREB pathway provides an early signal in the progression to NAFLD representing a noninvasive biomarker that can early detect NAFLD and a promising therapeutic target for the treatment of the disease as well.

14 December 2020 in Egyptian Liver Journal
Verified
Journal Article
Open access
PDF file
AAAshraf Awaad
Ashraf Awaad
MKMaher A. Kamel
Maher A. Kamel
MMMagdy M. Mohamed
Magdy M. Mohamed
MHMadiha H. Helmy
Madiha H. Helmy
MYMagda I. Youssef
Magda I. Youssef
MHMarwa G. A. Hegazy
Marwa G. A. Hegazy
An amendment to this paper has been published and can be accessed via the original article.